This content is currently locked.

Your current Info-Tech Research Group subscription does not include access to this content. Contact your account representative gain access to Healthcare.

Contact Your Representative
Or Call Us: 1-888-670-8889

Date published:

10/18/2017

Watson for Oncology is IBM’s supercomputer solution, which claims to help “…doctors out-think cancer…,” may be more marketing than medicine. Despite being released to market in 2014, recent research reveals an IBM product that is not living up to the marketing hype, lacks substantive peer-reviewed scientific evaluations, and carries a staggeringly high total cost of ownership. IT leaders may be served best by allowing the competition to fund this product’s evolving technology.
Author:
  • Scott Bickley

Visit our COVID-19 Resource Center and our Cost Management Center
Over 100 analysts waiting to take your call right now: 1-519-432-3550 x2019